P2RY8: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
imported>Ser Amantio di Nicolao m (Moving from Category:G protein coupled receptors to Category:G protein-coupled receptors using Cat-a-lot) |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
'''P2Y purinoceptor 8''' is a [[protein]] that in humans is encoded by the ''P2RY8'' [[gene]].<ref name="pmid11004484">{{cite journal | vauthors = Adrian K, Bernhard MK, Breitinger HG, Ogilvie A | title = Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells | journal = Biochimica et Biophysica Acta | volume = 1492 | issue = 1 | pages = 127–38 | date = Jun 2000 | pmid = 11004484 | pmc = | doi = 10.1016/S0167-4781(00)00094-4 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: P2RY8 purinergic receptor P2Y, G-protein coupled, 8| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=286530| accessdate = }}</ref> | |||
== Function == | |||
The protein encoded by this gene belongs to the family of G-protein coupled receptors, that are preferentially activated by adenosine and uridine nucleotides. This gene is moderately expressed in undifferentiated HL60 cells, and is located on both chromosomes X and Y.<ref name="entrez"/> | |||
== Clinical relevance == | |||
Recurrent mutations in this gene have been associated to cases of [[diffuse large B-cell lymphoma]].<ref name=pmid.22343534>{{cite journal | vauthors = Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR | title = Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 109 | issue = 10 | pages = 3879–84 | date = Mar 2012 | pmid = 22343534 | pmc = 3309757 | doi = 10.1073/pnas.1121343109 }}</ref> | |||
==See also== | == See also == | ||
* [[P2Y receptor]] | * [[P2Y receptor]] | ||
==References== | == References == | ||
{{reflist}} | {{reflist}} | ||
==Further reading== | == Further reading == | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Cantagrel V, Lossi AM, Boulanger S, Depetris D, Mattei MG, Gecz J, Schwartz CE, Van Maldergem L, Villard L | title = Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males | journal = Journal of Medical Genetics | volume = 41 | issue = 10 | pages = 736–42 | date = Oct 2004 | pmid = 15466006 | pmc = 1735597 | doi = 10.1136/jmg.2004.021626 }} | |||
* {{cite journal | vauthors = Fujiwara S, Yamashita Y, Choi YL, Watanabe H, Kurashina K, Soda M, Enomoto M, Hatanaka H, Takada S, Ozawa K, Mano H | title = Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening | journal = Leukemia & Lymphoma | volume = 48 | issue = 5 | pages = 978–86 | date = May 2007 | pmid = 17487742 | doi = 10.1080/10428190701225882 }} | |||
*{{cite journal | * {{cite journal | vauthors = Storlazzi CT, Albano F, Lo Cunsolo C, Doglioni C, Guastadisegni MC, Impera L, Lonoce A, Funes S, Macrì E, Iuzzolino P, Panagopoulos I, Specchia G, Rocchi M | title = Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma | journal = Leukemia | volume = 21 | issue = 10 | pages = 2221–5 | date = Oct 2007 | pmid = 17554380 | doi = 10.1038/sj.leu.2404784 }} | ||
*{{cite journal | |||
*{{cite journal | |||
}} | |||
{{refend}} | {{refend}} | ||
{{NLM content}} | {{NLM content}} | ||
{{G protein-coupled receptors}} | {{G protein-coupled receptors}} | ||
{{Purinergics}} | |||
[[Category:G protein-coupled receptors]] | |||
{{ | {{transmembranereceptor-stub}} |
Latest revision as of 18:01, 24 September 2018
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
P2Y purinoceptor 8 is a protein that in humans is encoded by the P2RY8 gene.[1][2]
Function
The protein encoded by this gene belongs to the family of G-protein coupled receptors, that are preferentially activated by adenosine and uridine nucleotides. This gene is moderately expressed in undifferentiated HL60 cells, and is located on both chromosomes X and Y.[2]
Clinical relevance
Recurrent mutations in this gene have been associated to cases of diffuse large B-cell lymphoma.[3]
See also
References
- ↑ Adrian K, Bernhard MK, Breitinger HG, Ogilvie A (Jun 2000). "Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells". Biochimica et Biophysica Acta. 1492 (1): 127–38. doi:10.1016/S0167-4781(00)00094-4. PMID 11004484.
- ↑ 2.0 2.1 "Entrez Gene: P2RY8 purinergic receptor P2Y, G-protein coupled, 8".
- ↑ Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR (Mar 2012). "Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing". Proceedings of the National Academy of Sciences of the United States of America. 109 (10): 3879–84. doi:10.1073/pnas.1121343109. PMC 3309757. PMID 22343534.
Further reading
- Cantagrel V, Lossi AM, Boulanger S, Depetris D, Mattei MG, Gecz J, Schwartz CE, Van Maldergem L, Villard L (Oct 2004). "Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males". Journal of Medical Genetics. 41 (10): 736–42. doi:10.1136/jmg.2004.021626. PMC 1735597. PMID 15466006.
- Fujiwara S, Yamashita Y, Choi YL, Watanabe H, Kurashina K, Soda M, Enomoto M, Hatanaka H, Takada S, Ozawa K, Mano H (May 2007). "Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening". Leukemia & Lymphoma. 48 (5): 978–86. doi:10.1080/10428190701225882. PMID 17487742.
- Storlazzi CT, Albano F, Lo Cunsolo C, Doglioni C, Guastadisegni MC, Impera L, Lonoce A, Funes S, Macrì E, Iuzzolino P, Panagopoulos I, Specchia G, Rocchi M (Oct 2007). "Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma". Leukemia. 21 (10): 2221–5. doi:10.1038/sj.leu.2404784. PMID 17554380.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it. |